CoreCap Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2K Buy
136
+38
+39% +$2.73K ﹤0.01% 2060
2026
Q1
$6.98K Sell
98
-9
-8% -$615 ﹤0.01% 2088
2025
Q4
$6.33K Sell
107
-6
-5% -$326 ﹤0.01% 2113
2025
Q3
$6.24K Sell
113
-52
-32% -$2.7K ﹤0.01% 2111
2025
Q2
$7.11K Buy
165
+88
+114% +$3.4K ﹤0.01% 2007
2025
Q1
$3.05K Buy
+77
New +$3.41K ﹤0.01% 2234
2022
Q4
$70 Buy
+1
New +$70 ﹤0.01% 2325
2022
Q3
Sell
-3
Closed 1520
2022
Q2
$0 Buy
+3
New +$196 ﹤0.01% 2226
2022
Q1
Sell
-3
Closed -$1K 1509
2021
Q4
$1K Buy
+3
New +$228 ﹤0.01% 2191

Other funds holding NGVT

CoreCap Advisors's NGVT Position: Q2 2026 in Review

CoreCap Advisors increased its Ingevity (NGVT) stake by 39% in Q2 2026, buying an estimated $2.73K and bringing the position to 136 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

CoreCap Advisors first reported a position in NGVT in Q4 2021 and has held it in 9 quarters since. 43 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • CoreCap Advisors held 136 shares of Ingevity worth $10.2K as of Q2 2026.
  • CoreCap Advisors bought 38 Ingevity shares in Q2 2026, an estimated $2.73K.
  • Ingevity made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2060 holding.
  • CoreCap Advisors first reported a position in Ingevity in Q4 2021 and has held it in 9 quarters since.
  • 43 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.